miR-21-5p-loaded bone mesenchymal stem cell-derived exosomes repair ovarian function in autoimmune premature ovarian

Yutao Yang1, Lichao Tang1, Yuanling Xiao1

  • 1Department of Obstetrics and Gynecology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

PubMed
Abstract

Insights

Micro-RNA (miR)-21-5p-loaded exosomes (miR-21-Exo) from mesenchymal stem cells improve ovarian function in autoimmune premature ovarian insufficiency (POI). This therapy targets the MSX1-Notch pathway to reduce granulosa cell apoptosis and enhance hormone synthesis.

Area of Science:

  • Reproductive biology
  • Cell biology
  • Molecular medicine

Background:

  • Autoimmune premature ovarian insufficiency (POI) poses significant challenges in reproductive health.
  • Understanding the molecular mechanisms underlying POI is crucial for developing effective therapies.
  • Mesenchymal stem cell-derived exosomes show therapeutic potential in various diseases.

Purpose of the Study:

  • To investigate the therapeutic effect of micro-RNA (miR)-21-5p-loaded bone marrow mesenchymal stem cell-derived exosomes (miR-21-Exo) on autoimmune premature ovarian insufficiency (POI).
  • To elucidate the underlying molecular mechanisms involving Msh homeobox 1 (MSX1) and the Notch signalling pathway.

Main Methods:

  • Cell Counting Kit 8 (CCK8) assay, fluorescence-activated cell sorting, western blotting, qRT-PCR, and ELISA were used to assess miR-21-Exo effects on KGN cells.
  • Dual-luciferase reporter gene assays, qRT-PCR, and western blotting were employed to verify the interaction between miR-21 and MSX1 and pathway regulation.
  • In vivo studies in a mouse model of autoimmune POI included oestrous cycle monitoring, histological analysis (H&E), follicle counts, ELISA, immunohistochemistry, TUNEL assay, western blotting, and qRT-PCR.

Main Results:

  • miR-21-Exo promoted proliferation and hormone synthesis while inhibiting apoptosis in interferon-γ (IFN-γ)-induced KGN cells.
  • Direct interaction between miR-21 and MSX1 was confirmed, revealing miR-21-Exo's role in mediating MSX1 to regulate the Notch signalling pathway.
  • In vivo, miR-21-Exo restored ovarian structure, enhanced endocrine function and proliferation, and reduced apoptosis and inflammation in autoimmune POI mice.

Conclusions:

  • miR-21-Exo effectively treats autoimmune POI by regulating the MSX1-mediated Notch signalling pathway.
  • This mechanism inhibits granulosa cell apoptosis and improves hormone synthesis, offering a novel molecular therapy approach for POI.